These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19427615)

  • 1. Antiphospholipid antibodies may impair factor XIIa-dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies.
    Lázaro I; Carmona F; Reverter JC; Cervera R; Tassies D; Balasch J
    Am J Obstet Gynecol; 2009 Jul; 201(1):87.e1-6. PubMed ID: 19427615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications.
    Carmona F; Lázaro I; Reverter JC; Tàssies D; Font J; Cervera R; Balasch J
    Am J Obstet Gynecol; 2006 Feb; 194(2):457-65. PubMed ID: 16458646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes.
    Clemens N; Frauenknecht K; Katzav A; Sommer C; von Landenberg P
    Ann N Y Acad Sci; 2009 Sep; 1173():805-13. PubMed ID: 19758232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
    Rand JH; Wu XX; Andree HA; Lockwood CJ; Guller S; Scher J; Harpel PC
    N Engl J Med; 1997 Jul; 337(3):154-60. PubMed ID: 9219701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?
    Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW
    Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiphospholipid antibodies and thrombosis: the putative mechanisms of hypercoagulable state in patients with anticardiolipin antibody].
    Ieko M
    Rinsho Byori; 2000 Apr; 48(4):293-300. PubMed ID: 10810873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells.
    Vega-Ostertag M; Liu X; Kwan-Ki H; Chen P; Pierangeli S
    Br J Haematol; 2006 Oct; 135(2):214-9. PubMed ID: 16965389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
    Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells.
    Patterson AM; Ford I; Graham A; Booth NA; Greaves M
    Br J Haematol; 2006 May; 133(3):323-30. PubMed ID: 16643435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay.
    Gardiner C; Cohen H; Jenkins A; Machin SJ; Mackie IJ
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):477-83. PubMed ID: 16905952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
    Yasuda S; Atsumi T; Ieko M; Koike T
    Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
    Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
    Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The increased rate of activation of factor XII in late pregnancy can contribute to the increased reactivity of factor VII.
    Mitropoulos KA; Martin JC; Burgess AI; Esnouf MP; Stirling Y; Howarth DJ; Reeves BE
    Thromb Haemost; 1990 Jun; 63(3):349-55. PubMed ID: 2402739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.
    Bu C; Zhang C; Li Z; Gao L; Xie Z; Cai G
    Clin Exp Immunol; 2007 Jul; 149(1):31-9. PubMed ID: 17425656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiprothrombin antibody testing: detection and clinical utility.
    Oku K; Atsumi T; Amengual O; Koike T
    Semin Thromb Hemost; 2008 Jun; 34(4):335-9. PubMed ID: 18814066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
    Adams M
    Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
    Pierangeli SS; Chen PP; Raschi E; Scurati S; Grossi C; Borghi MO; Palomo I; Harris EN; Meroni PL
    Semin Thromb Hemost; 2008 Apr; 34(3):236-50. PubMed ID: 18720303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome.
    Pierangeli SS; Vega-Ostertag ME; González EB
    Expert Rev Mol Med; 2007 Nov; 9(30):1-15. PubMed ID: 17997880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C.
    Galli M; Willems GM; Rosing J; Janssen RM; Govers-Riemslag JW; Comfurius P; Barbui T; Zwaal RF; Bevers EM
    Br J Haematol; 2005 Apr; 129(2):240-7. PubMed ID: 15813852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.